Private Capital Group, LLC Vir Biotechnology, Inc. Transaction History

Private Capital Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$21.19 - $40.01 $678 - $1,280	-32 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$30.97 - $54.03 $991 - $1,728	32 New	32 $1,000
Q3 2021 Oct 13, 2021	SELL	$34.9 - $54.54 $1,047 - $1,636	-30 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$38.75 - $51.0 $1,162 - $1,530	30 New	30 $1,000
Q3 2020 Nov 12, 2020	SELL	$28.28 - $53.6 $820 - $1,554	-29 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$27.89 - $47.86 $808 - $1,387	29 New	29 $1,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.